Abstract
The aim of this review is to summarize recent developments in the treatment of uveitic macular edema (ME). ME represent a major cause of visual loss in uveitis and adequate management is crucial for the maintenance of useful vision in patients with chronic uveitis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 30-37 |
| Number of pages | 8 |
| Journal | Current Ophthalmology Reports |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1 2016 |
Keywords
- Corticosteroids
- Immunosuppressive therapy
- Inflammation
- Inflammatory edema
- Uveitic macular edema
- Uveitis
ASJC Scopus subject areas
- Ophthalmology
Fingerprint Dive into the research topics of 'Uveitic Macular Edema: Treatment Update'. Together they form a unique fingerprint.
Cite this
Goldhardt, R., & Rosen, B. S. (2016). Uveitic Macular Edema: Treatment Update. Current Ophthalmology Reports, 4(1), 30-37. https://doi.org/10.1007/s40135-016-0090-3